[ad_1]
Healthy earnings CAGR of 10-11% expected over the next 3-5 years; estimates fine-tuned; valuations are attractive; ‘Buy’ retained
[ad_2]
Source link
[ad_1]
Healthy earnings CAGR of 10-11% expected over the next 3-5 years; estimates fine-tuned; valuations are attractive; ‘Buy’ retained
[ad_2]
Source link
Copyright © 2024 SCORE REVIVE